Brief: Valirx Announces Evaluation Agreement With Stingray Bio

ValiRx

10/11/2023 07:20

Nov 10 (Reuters) - ValiRx PLC  VALX.L :
    * VALIRX PLC  - EVALUATION AGREEMENT WITH STINGRAY BIO
    * VALIRX PLC - ENTERED INTO AN AGREEMENT WITH STINGRAY BIO
LIMITED
TO INVESTIGATE A LEAD SERIES OF DRUG CANDIDATES FOR USE IN
ONCOLOGY
    * VALIRX PLC - COST OF WORK WILL BE BORNE BY VALIRX AND WILL
BE
CAPPED AT £100,000 OVER TWELVE MONTH PERIOD
    * VALIRX PLC - AT CONCLUSION OF EVALUATION PERIOD COMPANY
HAS AN
OPTION TO LICENSE TECHNOLOGY ON PRE-AGREED TERMS

Source text for Eikon:  ID:nRSJ0139Ta 
Further company coverage:  VALX.L